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Cucurbiturils as supramolecular inhibitors of DNA
restriction by type II endonucleases†
Cátia Parente Carvalho,a Amir Norouzy,b Vera Ribeiro,c Werner M. Naub and
Uwe Pischel*a
Cucurbiturils (CB6 and CB7) were shown to inhibit the enzymati-
cally catalyzed restriction of plasmids and linear DNA. This eﬀect
can be inverted by supramolecular masking of the macrocycles
through competitive complexation with polyamines. These
experiments provide supramolecular control of biocatalytic
processes.
Introduction
Cucurbit[n]urils (CBn) are water-soluble macrocyclic hosts fea-
turing n glycoluril units linked by methylene bridges (see CB6
and CB7 in Scheme 1).1–5 Thus far the homologues with n = 6,
7, and 8 have received most attention in supramolecular appli-
cations, many of which are biologically related.5–21 The poten-
tial of CBn macrocycles to control functions in biological
chemistry via reversible supramolecular interactions benefits
from their good water solubility, high binding constants,22
and low cellular toxicity.23,24
According to strategies (a) and (b), shown in Scheme 2,
several protocols for biological control by cucurbiturils have
been developed. For instance, CB7 is known to protect pep-
tides from protease-catalyzed hydrolytic degradation, which is
an example of substrate-related supramolecular control of bio-
logical functions by CBn macrocycles (strategy (a)).10,25 As an
example for path (b) CB7 can complex inhibitors of bovine car-
bonic anhydrase or acetylcholinesterase and, thereby, activate
catalytic reactions through competitive displacement of the
inhibitor from the enzyme.26 In the context of enzymatic trans-
formations of DNA substrates, it was shown that the spermidine·
CB6 complex (3·CB6) catalyzes the topoisomerization of
supercoiled plasmid DNA and that CB6 can invert the promot-
ing eﬀect of spermine (4) in plasmid DNA restriction (strategy
(b)).27 It is noteworthy that while there are case studies of
organic hosts that interact with enzymes or other proteins,28–31
the direct modulation of the biocatalytic activity of the enzyme
itself by CBn hosts has remained elusive. In the course of our
research on cucurbituril–biomolecule interactions, we came
across an unprecedented inhibition of DNA restriction, a
process that plays a fundamental role in the defense of organ-
isms against foreign DNA.
Scheme 1 Structures of polyamines 1–4 and CBn host macrocycles.
Scheme 2 Supramolecular control of enzymatic catalysis by host
macrocycles (e.g., CBn) via (a) substrate binding or (b) inhibitor binding.
E: enzyme, S: substrate, I: inhibitor.
†Electronic supplementary information (ESI) available: DNA extraction, details
of restriction assays, control experiments (CBn–DNA interaction, EDTA addition),
and amino acid sequences of the investigated enzymes. See DOI: 10.1039/
c4ob02122c
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Results and discussion
The first example is the hydrolysis of DNA at GGTACC sites
catalyzed by the endonuclease KpnI (see Fig. 1a). Fig. 1a shows
the corresponding experiments with plasmid pGL3-Basic DNA
as a substrate, which were conducted under identical con-
ditions concerning pH, buﬀer composition, temperature, and
digestion time.‡ The electrophoresis of the plasmid DNA alone
evidenced its preferential presence in the supercoiled form
(lane 1). Upon enzymatic hydrolysis of the plasmid DNA, the
linear form appeared (lane 2). However, in the presence of
6 μM CB6 ([CB6]/[KpnI] = 4542, lane 3) the enzymatic reaction
was significantly hindered leading to 47% inhibition with
respect to the absence of the macrocycle. The incomplete enzy-
matic reaction was confirmed by the observation of a substan-
tial amount of non-restricted plasmid DNA. The restriction
reaction can be re-activated by the addition of the strongly
competitive polycationic binder 4 (K = 3.3 × 109 M−1);32 lane
5 with [4]/[CB6] = 1. As a control experiment, the enzymatic
hydrolysis was also performed in the presence of 4 but in
the absence of CB6 (lane 4 vs. 5). The result confirmed
that 4 alone had no eﬀect on the DNA restriction under
the selected experimental conditions. The re-activation
was also seen for the addition of a stoichiometric amount of
the strongly CB6-binding amine 3 (K = 4.1 × 108 M−1); see
ESI.†32
In another series of experiments,‡ CB7 was used as a supra-
molecular inhibitor of the restriction of plasmid or linearized
pGL3-Basic DNA by various endonucleases (KpnI, SacI, and
XapI).§ The results are shown in Table 1. First, the macrocycle
concentration was adjusted to aﬀect ca. 50% inhibition, which
required 90–500 μM CB7 (Table 1). Second, polyamines 1–3
were screened for their potential to fully re-activate the DNA
restriction, which required 1–5 equivalents of a competitor,
depending on their relative aﬃnity to the macrocycle (see stoi-
chiometries in Table 1). As a representative example, the elec-
trophoretic analysis of the KpnI-induced hydrolysis of linear
pGL3-Basic DNA, its inhibition by CB7, and the re-activation
by addition of 1 is shown in Fig. 1b. The DNA (lane 1) showed
a band corresponding to the expected 4818 base pairs (bp).
The restriction reaction (lane 2) led to fragments with 3747
and 1071 bp. The presence of 200 μM CB7 (lane 3) hindered
the enzymatic hydrolysis (48% inhibition), which was reflected
by a substantial residual band of unrestricted DNA (4818 bp).
The addition of amine 1 ([1]/[CB7] = 5) blocked CB7 and
thereby re-activated the process again (lane 5). Lane 4 shows
the control in the presence of only 1 for which no eﬀect was
observed. While it is known that polyamines also bind to
DNA,33 their apparent binding constants are ca. 1–2 orders of
magnitude lower than the ones for the respective CB7 com-
plexes (compared to the CB6 complexes they are even ca. 3–4
orders of magnitude lower). This excludes competition
between CBn and DNA for the added polyamines under the
experimental conditions.‡
The variety of DNA conformations and endonucleases, for
which the inhibition by CBn was observed, points to a general
eﬀect. A previous literature report ruled out significant supra-
molecular interactions between CBn and DNA, based on the
absence of competitive displacement of a DNA-intercalating
dye.21 In line with this, our own circular dichroism (CD)
spectroscopic measurements did not reveal any sign of direct
supramolecular interaction between model DNA and CBn (see
ESI†). Additional support came from the observation of
unchanged gel mobility of circular and linear pGL3-Basic DNA
in the absence and presence of excess macrocycles (see ESI†).
On this basis, an interaction with the DNA substrate was ruled
out as the reason for the inhibitory eﬀect. The possibility of
metal-ion sequestration from the buﬀer solution by CBn is
another factor that deserved scrutiny.34 In particular, mag-
Table 1 Restriction assays (KpnI, SacI, and XapI endonucleases) of
plasmid and linear pGL3-Basic DNA in the presence of CB7 as a macro-
cycle and re-activation by addition of the polyamines putrescine (1),
cadaverine (2), and spermidine (3)
Plasmid DNA Linear DNAa
KpnIb SacIc XapId KpnIb SacIc XapId
[CB7]/μMe 90 250 500 200 350 500
Inhibition (%) 32 42 54 48 52 58
[1]/[CB7] f 5 5 5 5 5 5
[2]/[CB7] f 1 2 2 1 2 2
[3]/[CB7] f 2 1 1 2 1 1
aObtained by total restriction of plasmid pGL3-Basic DNA with PdmI
endonuclease. b Restriction at GGTACC sites. c Restriction at GAGCTC
sites. d Restriction at RAATTY sites. eOptimized CB7 concentration to
achieve ca. 50% inhibition. fOptimized polyamine/macrocycle ratio for
complete re-activation (<5% inhibition); binding constants (K/106 M−1)
with CB7 in water at pH 7 (this work): 0.11 for 1, 20 for 2, and 1.2
for 3.
Fig. 1 Electrophoretic analysis of KpnI enzymatic hydrolysis of (a)
plasmid pGL3-Basic DNA (lane 1: DNA alone; lane 2: reaction in the
absence of other additives; lane 3: reaction in the presence of CB6; lane
4: reaction in the presence of only 4; lane 5: reaction in the presence of
stoichiometric amounts of 4 and CB6; C = relaxed/nicked circular DNA;
L = linear DNA; S = supercoiled DNA) and (b) the same set of experi-
ments but with linear pGL3-Basic DNA as a substrate, CB7 as a host, and
1 as a competitive binder in 5-fold excess.
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nesium ions (Mg2+) are known to serve as an essential cofactor
of the type II endonucleases employed herein.35 A control
experiment revealed that EDTA (1 mM), a strong Mg2+ chelator,
did not lead to endonuclease inhibition as tested for the
example of XapI; see ESI.† The EDTA concentration corres-
ponds to double the CB7 concentration used for the experi-
ments with this enzyme. This rules out metal-ion
sequestration as a cause of the observed inhibition, at least at
the applied CBn concentrations (maximum of 500 μM). It is
noteworthy that, bovine serum albumin (BSA) is often present
in the digestion solutions, fulfilling the role of a stabilizer and
a protective agent against impurities that may be problematic
for the restriction reaction. On the one hand, for the BSA con-
centration used in our assays (ca. 1.5 μM for KpnI and XapI;
note that SacI does not require BSA) no protection against the
inhibitory action of CBn was noted. Only at much higher BSA
concentrations (>30 μM; tested for the example of the XapI
assay) the CB-induced inhibition was suppressed. On the
other hand, the inhibitory action of CB7 in the absence of BSA
was maintained (observed for the example of KpnI in BSA-free
reaction buﬀer; see ESI†). Thereby, the interaction of CBn with
BSA can be excluded as well as the underlying reason for the
observed inhibitory eﬀect.
There is ample evidence in the literature for host–guest
interactions between CBn and peptides or proteins.13,36,37 It
is generally accepted that peptides with N-terminal
aromatic amino acids (Trp, Phe, Tyr) or long alkylamino
chains (Lys) can form strong complexes with CB7 or CB6,
respectively.13,14,38–40 However, also amino acids at the C-ter-
minus and even internal ones can form complexes, albeit
somewhat weaker.38–41 The binding of proteins to CBn is
naturally more complex and depends on the availability of the
mentioned amino acids at the surface of the biomolecular
structure. One example of an eﬃcient CBn–protein interaction
is that with insulin, which features an exposed Phe N-terminal
residue.16 Unfortunately, for the investigated restriction
enzymes, predictions on accessible binding sites for CBn are
not straightforward to make, especially because they are rich
in amino acids displaying the required recognition motifs
(Lys, Tyr, Trp, and Phe; see amino acid sequences of the
enzymes in ESI†). Additionally, their inhibitory action could be
caused by both, binding near the DNA binding domain of the
enzyme or through a more remote binding associated with an
allosteric eﬀect.16
Unfortunately, our eﬀorts to obtain direct experimental
evidence (by UV-vis absorption spectroscopy, CD spectroscopy
or MALDI-TOF mass spectrometry) for the interaction between
the CBn macrocycles and the enzymes were hampered, among
others, by the presence of significant concentrations of BSA.
However, other possible reasons for the observed inhibitory
eﬀect, such as interactions with the substrate itself, metal–ion
sequestration, or masking of buﬀer components were clearly
excluded (see above). The combined experimental observations
and the literature precedence of protein–CBn interactions
provide at least an indirect hint on the origins of the observed
eﬀects as proposed in Scheme 3.
Conclusions
In conclusion, we demonstrated that CBn macrocycles can
inhibit the enzymatic hydrolysis of DNA substrates. The revers-
ible nature of the observed eﬀects was underpinned by the suc-
cessful re-activation of the type II endonuclease activity via
addition of CBn-binding polyamines. The supramolecular
methodology could find potential applications in molecular
biology, where42 the use of restriction enzymes plays a crucial
role.
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Notes and references
‡Reaction conditions: [DNA] = 9.6 nM corresponding to [bp] = 46.3 μM; [KpnI] =
0.5 U μL−1 in a 10 mM Tris-HCl buﬀer (pH 7.5) containing 10 mM MgCl2, 0.02%
Triton X-100, 0.1 mg mL−1 bovine serum albumin (BSA); [SacI] = 0.5 U μL−1 in
10 mM Tris-HCl buﬀer (pH 7.5) containing 7 mM MgCl2, 50 mM KCl, 1 mM
DTT; [XapI] = 0.025 U μL−1 in 33 mM Tris-acetate buﬀer (pH 7.9) containing
10 mM Mg(OAc)2, 66 mM KOAc, 0.1 mg mL
−1 BSA; all at 37 °C for 3 h.
The degree of inhibition was evaluated by integration of the optical density of
electrophoresis DNA bands by using the ImageJ program.43 Each experiment was
carried out at least three times.
Scheme 3 Schematic illustration of the postulated inhibition of DNA
restriction enzymes by CBn hosts and their re-activation by competitive
binding with polyamines.
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§The plasmid pGL3-Basic DNA was amplified in DH5α E. coli cells (see ESI†)
and purified using the NucleoBond® Xtra Midi EF kit from Macherey-Nagel. The
plasmid DNA was linearized by total restriction with PdmI endonuclease ([DNA] =
383.8 nM; [PdmI] = 2 U μL−1, 33 mM Tris-acetate buﬀer (pH 7.9), 10 mM
Mg(OAc)2, 66 mM KOAc, 0.1 mg mL
−1 BSA; 37 °C for 12 h) and purification by
ethanol precipitation. The enzymes KpnI, XapI, and PdmI were purchased from
Thermo Scientific. SacI was available from Promega. KpnI without added BSA
was supplied by Sigma-Aldrich. Additional information about the enzymes is
available at http://rebase.neb.com.44
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